Global Radiopharmaceutical Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Radiopharmaceutical market size is predicted to grow from US$ 6961 million in 2025 to US$ 10770 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
LP Information, Inc. (LPI) ' newest research report, the “Radiopharmaceutical Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical sales in 2024, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical sales for 2025 through 2031. With Radiopharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiopharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Radiopharmaceutical market?
What factors are driving Radiopharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceutical market opportunities vary by end market size?
How does Radiopharmaceutical break out by Type, by Application?
The global Radiopharmaceutical market size is predicted to grow from US$ 6961 million in 2025 to US$ 10770 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
LP Information, Inc. (LPI) ' newest research report, the “Radiopharmaceutical Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical sales in 2024, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical sales for 2025 through 2031. With Radiopharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiopharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Oncology
- Cardiology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cardinal Health
- GE Healthcare
- Jubilant Pharma
- Novartis
- Curium Pharma
- SIEMENS
- Lantheus
- Bracco Imaging
- Bayer
- Eli Lilly
- Aurobindo Pharma
- Mundipharma
- China Isotope & Radiation
- Dongcheng
What is the 10-year outlook for the global Radiopharmaceutical market?
What factors are driving Radiopharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceutical market opportunities vary by end market size?
How does Radiopharmaceutical break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Radiopharmaceutical by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Radiopharmaceutical by Country/Region, 2020, 2024 & 2031
2.2 Radiopharmaceutical Segment by Type
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapeutic Radiopharmaceuticals
2.3 Radiopharmaceutical Sales by Type
2.3.1 Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2020-2025)
2.3.3 Global Radiopharmaceutical Sale Price by Type (2020-2025)
2.4 Radiopharmaceutical Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Sales by Application
2.5.1 Global Radiopharmaceutical Sale Market Share by Application (2020-2025)
2.5.2 Global Radiopharmaceutical Revenue and Market Share by Application (2020-2025)
2.5.3 Global Radiopharmaceutical Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Radiopharmaceutical Breakdown Data by Company
3.1.1 Global Radiopharmaceutical Annual Sales by Company (2020-2025)
3.1.2 Global Radiopharmaceutical Sales Market Share by Company (2020-2025)
3.2 Global Radiopharmaceutical Annual Revenue by Company (2020-2025)
3.2.1 Global Radiopharmaceutical Revenue by Company (2020-2025)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Company (2020-2025)
3.3 Global Radiopharmaceutical Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical Product Location Distribution
3.4.2 Players Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceutical Market Size by Geographic Region (2020-2025)
4.1.1 Global Radiopharmaceutical Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Radiopharmaceutical Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Radiopharmaceutical Market Size by Country/Region (2020-2025)
4.2.1 Global Radiopharmaceutical Annual Sales by Country/Region (2020-2025)
4.2.2 Global Radiopharmaceutical Annual Revenue by Country/Region (2020-2025)
4.3 Americas Radiopharmaceutical Sales Growth
4.4 APAC Radiopharmaceutical Sales Growth
4.5 Europe Radiopharmaceutical Sales Growth
4.6 Middle East & Africa Radiopharmaceutical Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceutical Sales by Country
5.1.1 Americas Radiopharmaceutical Sales by Country (2020-2025)
5.1.2 Americas Radiopharmaceutical Revenue by Country (2020-2025)
5.2 Americas Radiopharmaceutical Sales by Type (2020-2025)
5.3 Americas Radiopharmaceutical Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Sales by Region
6.1.1 APAC Radiopharmaceutical Sales by Region (2020-2025)
6.1.2 APAC Radiopharmaceutical Revenue by Region (2020-2025)
6.2 APAC Radiopharmaceutical Sales by Type (2020-2025)
6.3 APAC Radiopharmaceutical Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceutical by Country
7.1.1 Europe Radiopharmaceutical Sales by Country (2020-2025)
7.1.2 Europe Radiopharmaceutical Revenue by Country (2020-2025)
7.2 Europe Radiopharmaceutical Sales by Type (2020-2025)
7.3 Europe Radiopharmaceutical Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical by Country
8.1.1 Middle East & Africa Radiopharmaceutical Sales by Country (2020-2025)
8.1.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2020-2025)
8.2 Middle East & Africa Radiopharmaceutical Sales by Type (2020-2025)
8.3 Middle East & Africa Radiopharmaceutical Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical
10.3 Manufacturing Process Analysis of Radiopharmaceutical
10.4 Industry Chain Structure of Radiopharmaceutical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical Distributors
11.3 Radiopharmaceutical Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceutical Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical Forecast by Region (2026-2031)
12.1.2 Global Radiopharmaceutical Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Radiopharmaceutical Forecast by Type (2026-2031)
12.7 Global Radiopharmaceutical Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Cardinal Health
13.1.1 Cardinal Health Company Information
13.1.2 Cardinal Health Radiopharmaceutical Product Portfolios and Specifications
13.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Main Business Overview
13.1.5 Cardinal Health Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
13.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Jubilant Pharma
13.3.1 Jubilant Pharma Company Information
13.3.2 Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
13.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jubilant Pharma Main Business Overview
13.3.5 Jubilant Pharma Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Radiopharmaceutical Product Portfolios and Specifications
13.4.3 Novartis Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Radiopharmaceutical Product Portfolios and Specifications
13.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 SIEMENS
13.6.1 SIEMENS Company Information
13.6.2 SIEMENS Radiopharmaceutical Product Portfolios and Specifications
13.6.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SIEMENS Main Business Overview
13.6.5 SIEMENS Latest Developments
13.7 Lantheus
13.7.1 Lantheus Company Information
13.7.2 Lantheus Radiopharmaceutical Product Portfolios and Specifications
13.7.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lantheus Main Business Overview
13.7.5 Lantheus Latest Developments
13.8 Bracco Imaging
13.8.1 Bracco Imaging Company Information
13.8.2 Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
13.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bracco Imaging Main Business Overview
13.8.5 Bracco Imaging Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Radiopharmaceutical Product Portfolios and Specifications
13.9.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
13.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Radiopharmaceutical Product Portfolios and Specifications
13.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Mundipharma
13.12.1 Mundipharma Company Information
13.12.2 Mundipharma Radiopharmaceutical Product Portfolios and Specifications
13.12.3 Mundipharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mundipharma Main Business Overview
13.12.5 Mundipharma Latest Developments
13.13 China Isotope & Radiation
13.13.1 China Isotope & Radiation Company Information
13.13.2 China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
13.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 China Isotope & Radiation Main Business Overview
13.13.5 China Isotope & Radiation Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical Product Portfolios and Specifications
13.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Radiopharmaceutical by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Radiopharmaceutical by Country/Region, 2020, 2024 & 2031
2.2 Radiopharmaceutical Segment by Type
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapeutic Radiopharmaceuticals
2.3 Radiopharmaceutical Sales by Type
2.3.1 Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2020-2025)
2.3.3 Global Radiopharmaceutical Sale Price by Type (2020-2025)
2.4 Radiopharmaceutical Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Sales by Application
2.5.1 Global Radiopharmaceutical Sale Market Share by Application (2020-2025)
2.5.2 Global Radiopharmaceutical Revenue and Market Share by Application (2020-2025)
2.5.3 Global Radiopharmaceutical Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Radiopharmaceutical Breakdown Data by Company
3.1.1 Global Radiopharmaceutical Annual Sales by Company (2020-2025)
3.1.2 Global Radiopharmaceutical Sales Market Share by Company (2020-2025)
3.2 Global Radiopharmaceutical Annual Revenue by Company (2020-2025)
3.2.1 Global Radiopharmaceutical Revenue by Company (2020-2025)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Company (2020-2025)
3.3 Global Radiopharmaceutical Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical Product Location Distribution
3.4.2 Players Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceutical Market Size by Geographic Region (2020-2025)
4.1.1 Global Radiopharmaceutical Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Radiopharmaceutical Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Radiopharmaceutical Market Size by Country/Region (2020-2025)
4.2.1 Global Radiopharmaceutical Annual Sales by Country/Region (2020-2025)
4.2.2 Global Radiopharmaceutical Annual Revenue by Country/Region (2020-2025)
4.3 Americas Radiopharmaceutical Sales Growth
4.4 APAC Radiopharmaceutical Sales Growth
4.5 Europe Radiopharmaceutical Sales Growth
4.6 Middle East & Africa Radiopharmaceutical Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceutical Sales by Country
5.1.1 Americas Radiopharmaceutical Sales by Country (2020-2025)
5.1.2 Americas Radiopharmaceutical Revenue by Country (2020-2025)
5.2 Americas Radiopharmaceutical Sales by Type (2020-2025)
5.3 Americas Radiopharmaceutical Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Sales by Region
6.1.1 APAC Radiopharmaceutical Sales by Region (2020-2025)
6.1.2 APAC Radiopharmaceutical Revenue by Region (2020-2025)
6.2 APAC Radiopharmaceutical Sales by Type (2020-2025)
6.3 APAC Radiopharmaceutical Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceutical by Country
7.1.1 Europe Radiopharmaceutical Sales by Country (2020-2025)
7.1.2 Europe Radiopharmaceutical Revenue by Country (2020-2025)
7.2 Europe Radiopharmaceutical Sales by Type (2020-2025)
7.3 Europe Radiopharmaceutical Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical by Country
8.1.1 Middle East & Africa Radiopharmaceutical Sales by Country (2020-2025)
8.1.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2020-2025)
8.2 Middle East & Africa Radiopharmaceutical Sales by Type (2020-2025)
8.3 Middle East & Africa Radiopharmaceutical Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical
10.3 Manufacturing Process Analysis of Radiopharmaceutical
10.4 Industry Chain Structure of Radiopharmaceutical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical Distributors
11.3 Radiopharmaceutical Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceutical Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical Forecast by Region (2026-2031)
12.1.2 Global Radiopharmaceutical Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Radiopharmaceutical Forecast by Type (2026-2031)
12.7 Global Radiopharmaceutical Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Cardinal Health
13.1.1 Cardinal Health Company Information
13.1.2 Cardinal Health Radiopharmaceutical Product Portfolios and Specifications
13.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Main Business Overview
13.1.5 Cardinal Health Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
13.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Jubilant Pharma
13.3.1 Jubilant Pharma Company Information
13.3.2 Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
13.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jubilant Pharma Main Business Overview
13.3.5 Jubilant Pharma Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Radiopharmaceutical Product Portfolios and Specifications
13.4.3 Novartis Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Radiopharmaceutical Product Portfolios and Specifications
13.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 SIEMENS
13.6.1 SIEMENS Company Information
13.6.2 SIEMENS Radiopharmaceutical Product Portfolios and Specifications
13.6.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SIEMENS Main Business Overview
13.6.5 SIEMENS Latest Developments
13.7 Lantheus
13.7.1 Lantheus Company Information
13.7.2 Lantheus Radiopharmaceutical Product Portfolios and Specifications
13.7.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lantheus Main Business Overview
13.7.5 Lantheus Latest Developments
13.8 Bracco Imaging
13.8.1 Bracco Imaging Company Information
13.8.2 Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
13.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bracco Imaging Main Business Overview
13.8.5 Bracco Imaging Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Radiopharmaceutical Product Portfolios and Specifications
13.9.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
13.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Radiopharmaceutical Product Portfolios and Specifications
13.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Mundipharma
13.12.1 Mundipharma Company Information
13.12.2 Mundipharma Radiopharmaceutical Product Portfolios and Specifications
13.12.3 Mundipharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mundipharma Main Business Overview
13.12.5 Mundipharma Latest Developments
13.13 China Isotope & Radiation
13.13.1 China Isotope & Radiation Company Information
13.13.2 China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
13.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 China Isotope & Radiation Main Business Overview
13.13.5 China Isotope & Radiation Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical Product Portfolios and Specifications
13.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceutical Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Radiopharmaceutical Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Diagnostic Radiopharmaceuticals
Table 4. Major Players of Therapeutic Radiopharmaceuticals
Table 5. Global Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 6. Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 7. Global Radiopharmaceutical Revenue by Type (2020-2025) & ($ million)
Table 8. Global Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Table 9. Global Radiopharmaceutical Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Radiopharmaceutical Sale by Application (2020-2025) & (K Dose)
Table 11. Global Radiopharmaceutical Sale Market Share by Application (2020-2025)
Table 12. Global Radiopharmaceutical Revenue by Application (2020-2025) & ($ million)
Table 13. Global Radiopharmaceutical Revenue Market Share by Application (2020-2025)
Table 14. Global Radiopharmaceutical Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 16. Global Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 17. Global Radiopharmaceutical Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 19. Global Radiopharmaceutical Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Radiopharmaceutical Producing Area Distribution and Sales Area
Table 21. Players Radiopharmaceutical Products Offered
Table 22. Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Radiopharmaceutical Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. Global Radiopharmaceutical Sales Market Share Geographic Region (2020-2025)
Table 27. Global Radiopharmaceutical Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Radiopharmaceutical Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Radiopharmaceutical Sales by Country/Region (2020-2025) & (K Dose)
Table 30. Global Radiopharmaceutical Sales Market Share by Country/Region (2020-2025)
Table 31. Global Radiopharmaceutical Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Radiopharmaceutical Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 34. Americas Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 35. Americas Radiopharmaceutical Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 37. Americas Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 38. APAC Radiopharmaceutical Sales by Region (2020-2025) & (K Dose)
Table 39. APAC Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 40. APAC Radiopharmaceutical Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 42. APAC Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 43. Europe Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 44. Europe Radiopharmaceutical Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 46. Europe Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & Africa Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 50. Middle East & Africa Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Radiopharmaceutical
Table 52. Key Market Challenges & Risks of Radiopharmaceutical
Table 53. Key Industry Trends of Radiopharmaceutical
Table 54. Radiopharmaceutical Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Radiopharmaceutical Distributors List
Table 57. Radiopharmaceutical Customer List
Table 58. Global Radiopharmaceutical Sales Forecast by Region (2026-2031) & (K Dose)
Table 59. Global Radiopharmaceutical Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Radiopharmaceutical Sales Forecast by Country (2026-2031) & (K Dose)
Table 61. Americas Radiopharmaceutical Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Radiopharmaceutical Sales Forecast by Region (2026-2031) & (K Dose)
Table 63. APAC Radiopharmaceutical Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Radiopharmaceutical Sales Forecast by Country (2026-2031) & (K Dose)
Table 65. Europe Radiopharmaceutical Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Radiopharmaceutical Sales Forecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & Africa Radiopharmaceutical Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Radiopharmaceutical Sales Forecast by Type (2026-2031) & (K Dose)
Table 69. Global Radiopharmaceutical Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Radiopharmaceutical Sales Forecast by Application (2026-2031) & (K Dose)
Table 71. Global Radiopharmaceutical Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Cardinal Health Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 73. Cardinal Health Radiopharmaceutical Product Portfolios and Specifications
Table 74. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Cardinal Health Main Business
Table 76. Cardinal Health Latest Developments
Table 77. GE Healthcare Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 78. GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
Table 79. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GE Healthcare Main Business
Table 81. GE Healthcare Latest Developments
Table 82. Jubilant Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 83. Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 84. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Jubilant Pharma Main Business
Table 86. Jubilant Pharma Latest Developments
Table 87. Novartis Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Radiopharmaceutical Product Portfolios and Specifications
Table 89. Novartis Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Curium Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 93. Curium Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 94. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Curium Pharma Main Business
Table 96. Curium Pharma Latest Developments
Table 97. SIEMENS Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 98. SIEMENS Radiopharmaceutical Product Portfolios and Specifications
Table 99. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. SIEMENS Main Business
Table 101. SIEMENS Latest Developments
Table 102. Lantheus Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 103. Lantheus Radiopharmaceutical Product Portfolios and Specifications
Table 104. Lantheus Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Lantheus Main Business
Table 106. Lantheus Latest Developments
Table 107. Bracco Imaging Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 108. Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
Table 109. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Bracco Imaging Main Business
Table 111. Bracco Imaging Latest Developments
Table 112. Bayer Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 113. Bayer Radiopharmaceutical Product Portfolios and Specifications
Table 114. Bayer Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Bayer Main Business
Table 116. Bayer Latest Developments
Table 117. Eli Lilly Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
Table 119. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. Aurobindo Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurobindo Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 124. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Aurobindo Pharma Main Business
Table 126. Aurobindo Pharma Latest Developments
Table 127. Mundipharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 128. Mundipharma Radiopharmaceutical Product Portfolios and Specifications
Table 129. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. Mundipharma Main Business
Table 131. Mundipharma Latest Developments
Table 132. China Isotope & Radiation Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 133. China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
Table 134. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. China Isotope & Radiation Main Business
Table 136. China Isotope & Radiation Latest Developments
Table 137. Dongcheng Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 138. Dongcheng Radiopharmaceutical Product Portfolios and Specifications
Table 139. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. Dongcheng Main Business
Table 141. Dongcheng Latest Developments
Table 1. Radiopharmaceutical Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Radiopharmaceutical Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Diagnostic Radiopharmaceuticals
Table 4. Major Players of Therapeutic Radiopharmaceuticals
Table 5. Global Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 6. Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 7. Global Radiopharmaceutical Revenue by Type (2020-2025) & ($ million)
Table 8. Global Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Table 9. Global Radiopharmaceutical Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Radiopharmaceutical Sale by Application (2020-2025) & (K Dose)
Table 11. Global Radiopharmaceutical Sale Market Share by Application (2020-2025)
Table 12. Global Radiopharmaceutical Revenue by Application (2020-2025) & ($ million)
Table 13. Global Radiopharmaceutical Revenue Market Share by Application (2020-2025)
Table 14. Global Radiopharmaceutical Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 16. Global Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 17. Global Radiopharmaceutical Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 19. Global Radiopharmaceutical Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Radiopharmaceutical Producing Area Distribution and Sales Area
Table 21. Players Radiopharmaceutical Products Offered
Table 22. Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Radiopharmaceutical Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. Global Radiopharmaceutical Sales Market Share Geographic Region (2020-2025)
Table 27. Global Radiopharmaceutical Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Radiopharmaceutical Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Radiopharmaceutical Sales by Country/Region (2020-2025) & (K Dose)
Table 30. Global Radiopharmaceutical Sales Market Share by Country/Region (2020-2025)
Table 31. Global Radiopharmaceutical Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Radiopharmaceutical Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 34. Americas Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 35. Americas Radiopharmaceutical Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 37. Americas Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 38. APAC Radiopharmaceutical Sales by Region (2020-2025) & (K Dose)
Table 39. APAC Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 40. APAC Radiopharmaceutical Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 42. APAC Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 43. Europe Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 44. Europe Radiopharmaceutical Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 46. Europe Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & Africa Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 50. Middle East & Africa Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Radiopharmaceutical
Table 52. Key Market Challenges & Risks of Radiopharmaceutical
Table 53. Key Industry Trends of Radiopharmaceutical
Table 54. Radiopharmaceutical Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Radiopharmaceutical Distributors List
Table 57. Radiopharmaceutical Customer List
Table 58. Global Radiopharmaceutical Sales Forecast by Region (2026-2031) & (K Dose)
Table 59. Global Radiopharmaceutical Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Radiopharmaceutical Sales Forecast by Country (2026-2031) & (K Dose)
Table 61. Americas Radiopharmaceutical Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Radiopharmaceutical Sales Forecast by Region (2026-2031) & (K Dose)
Table 63. APAC Radiopharmaceutical Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Radiopharmaceutical Sales Forecast by Country (2026-2031) & (K Dose)
Table 65. Europe Radiopharmaceutical Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Radiopharmaceutical Sales Forecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & Africa Radiopharmaceutical Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Radiopharmaceutical Sales Forecast by Type (2026-2031) & (K Dose)
Table 69. Global Radiopharmaceutical Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Radiopharmaceutical Sales Forecast by Application (2026-2031) & (K Dose)
Table 71. Global Radiopharmaceutical Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Cardinal Health Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 73. Cardinal Health Radiopharmaceutical Product Portfolios and Specifications
Table 74. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Cardinal Health Main Business
Table 76. Cardinal Health Latest Developments
Table 77. GE Healthcare Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 78. GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
Table 79. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GE Healthcare Main Business
Table 81. GE Healthcare Latest Developments
Table 82. Jubilant Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 83. Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 84. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Jubilant Pharma Main Business
Table 86. Jubilant Pharma Latest Developments
Table 87. Novartis Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Radiopharmaceutical Product Portfolios and Specifications
Table 89. Novartis Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Curium Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 93. Curium Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 94. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Curium Pharma Main Business
Table 96. Curium Pharma Latest Developments
Table 97. SIEMENS Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 98. SIEMENS Radiopharmaceutical Product Portfolios and Specifications
Table 99. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. SIEMENS Main Business
Table 101. SIEMENS Latest Developments
Table 102. Lantheus Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 103. Lantheus Radiopharmaceutical Product Portfolios and Specifications
Table 104. Lantheus Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Lantheus Main Business
Table 106. Lantheus Latest Developments
Table 107. Bracco Imaging Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 108. Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
Table 109. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Bracco Imaging Main Business
Table 111. Bracco Imaging Latest Developments
Table 112. Bayer Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 113. Bayer Radiopharmaceutical Product Portfolios and Specifications
Table 114. Bayer Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Bayer Main Business
Table 116. Bayer Latest Developments
Table 117. Eli Lilly Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
Table 119. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. Aurobindo Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurobindo Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 124. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Aurobindo Pharma Main Business
Table 126. Aurobindo Pharma Latest Developments
Table 127. Mundipharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 128. Mundipharma Radiopharmaceutical Product Portfolios and Specifications
Table 129. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. Mundipharma Main Business
Table 131. Mundipharma Latest Developments
Table 132. China Isotope & Radiation Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 133. China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
Table 134. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. China Isotope & Radiation Main Business
Table 136. China Isotope & Radiation Latest Developments
Table 137. Dongcheng Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 138. Dongcheng Radiopharmaceutical Product Portfolios and Specifications
Table 139. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. Dongcheng Main Business
Table 141. Dongcheng Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radiopharmaceutical
Figure 2. Radiopharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Radiopharmaceutical Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Radiopharmaceutical Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Radiopharmaceutical Sales Market Share by Country/Region (2024)
Figure 10. Radiopharmaceutical Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Diagnostic Radiopharmaceuticals
Figure 12. Product Picture of Therapeutic Radiopharmaceuticals
Figure 13. Global Radiopharmaceutical Sales Market Share by Type in 2025
Figure 14. Global Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Figure 15. Radiopharmaceutical Consumed in Oncology
Figure 16. Global Radiopharmaceutical Market: Oncology (2020-2025) & (K Dose)
Figure 17. Radiopharmaceutical Consumed in Cardiology
Figure 18. Global Radiopharmaceutical Market: Cardiology (2020-2025) & (K Dose)
Figure 19. Radiopharmaceutical Consumed in Other
Figure 20. Global Radiopharmaceutical Market: Other (2020-2025) & (K Dose)
Figure 21. Global Radiopharmaceutical Sale Market Share by Application (2024)
Figure 22. Global Radiopharmaceutical Revenue Market Share by Application in 2025
Figure 23. Radiopharmaceutical Sales by Company in 2025 (K Dose)
Figure 24. Global Radiopharmaceutical Sales Market Share by Company in 2025
Figure 25. Radiopharmaceutical Revenue by Company in 2025 ($ millions)
Figure 26. Global Radiopharmaceutical Revenue Market Share by Company in 2025
Figure 27. Global Radiopharmaceutical Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Radiopharmaceutical Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 30. Americas Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 31. APAC Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 32. APAC Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 33. Europe Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 34. Europe Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 36. Middle East & Africa Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 37. Americas Radiopharmaceutical Sales Market Share by Country in 2025
Figure 38. Americas Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Figure 39. Americas Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 40. Americas Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 41. United States Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Radiopharmaceutical Sales Market Share by Region in 2025
Figure 46. APAC Radiopharmaceutical Revenue Market Share by Region (2020-2025)
Figure 47. APAC Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 48. APAC Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 49. China Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 53. India Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Radiopharmaceutical Sales Market Share by Country in 2025
Figure 57. Europe Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Figure 58. Europe Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 59. Europe Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 60. Germany Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 61. France Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 68. Egypt Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Radiopharmaceutical in 2025
Figure 74. Manufacturing Process Analysis of Radiopharmaceutical
Figure 75. Industry Chain Structure of Radiopharmaceutical
Figure 76. Channels of Distribution
Figure 77. Global Radiopharmaceutical Sales Market Forecast by Region (2026-2031)
Figure 78. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Radiopharmaceutical Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Radiopharmaceutical Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Radiopharmaceutical
Figure 2. Radiopharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Radiopharmaceutical Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Radiopharmaceutical Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Radiopharmaceutical Sales Market Share by Country/Region (2024)
Figure 10. Radiopharmaceutical Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Diagnostic Radiopharmaceuticals
Figure 12. Product Picture of Therapeutic Radiopharmaceuticals
Figure 13. Global Radiopharmaceutical Sales Market Share by Type in 2025
Figure 14. Global Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Figure 15. Radiopharmaceutical Consumed in Oncology
Figure 16. Global Radiopharmaceutical Market: Oncology (2020-2025) & (K Dose)
Figure 17. Radiopharmaceutical Consumed in Cardiology
Figure 18. Global Radiopharmaceutical Market: Cardiology (2020-2025) & (K Dose)
Figure 19. Radiopharmaceutical Consumed in Other
Figure 20. Global Radiopharmaceutical Market: Other (2020-2025) & (K Dose)
Figure 21. Global Radiopharmaceutical Sale Market Share by Application (2024)
Figure 22. Global Radiopharmaceutical Revenue Market Share by Application in 2025
Figure 23. Radiopharmaceutical Sales by Company in 2025 (K Dose)
Figure 24. Global Radiopharmaceutical Sales Market Share by Company in 2025
Figure 25. Radiopharmaceutical Revenue by Company in 2025 ($ millions)
Figure 26. Global Radiopharmaceutical Revenue Market Share by Company in 2025
Figure 27. Global Radiopharmaceutical Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Radiopharmaceutical Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 30. Americas Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 31. APAC Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 32. APAC Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 33. Europe Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 34. Europe Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Radiopharmaceutical Sales 2020-2025 (K Dose)
Figure 36. Middle East & Africa Radiopharmaceutical Revenue 2020-2025 ($ millions)
Figure 37. Americas Radiopharmaceutical Sales Market Share by Country in 2025
Figure 38. Americas Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Figure 39. Americas Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 40. Americas Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 41. United States Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Radiopharmaceutical Sales Market Share by Region in 2025
Figure 46. APAC Radiopharmaceutical Revenue Market Share by Region (2020-2025)
Figure 47. APAC Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 48. APAC Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 49. China Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 53. India Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Radiopharmaceutical Sales Market Share by Country in 2025
Figure 57. Europe Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Figure 58. Europe Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 59. Europe Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 60. Germany Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 61. France Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Radiopharmaceutical Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Radiopharmaceutical Sales Market Share by Application (2020-2025)
Figure 68. Egypt Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Radiopharmaceutical Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Radiopharmaceutical in 2025
Figure 74. Manufacturing Process Analysis of Radiopharmaceutical
Figure 75. Industry Chain Structure of Radiopharmaceutical
Figure 76. Channels of Distribution
Figure 77. Global Radiopharmaceutical Sales Market Forecast by Region (2026-2031)
Figure 78. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Radiopharmaceutical Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Radiopharmaceutical Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2026-2031)
